Multidrug-resistant Bacteroides fragilis group on the rise in Europe?

Journal of Medical Microbiology

Volumn 61, Issue PART12, 2012, Pages 1784-1788

  Hartmeyer, G N ^a   Soki J ^b   Nagy, E ^b   Justesen, U S ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; MEROPENEM; METRONIDAZOLE; TIGECYCLINE; VANCOMYCIN;

AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTEROIDES FRAGILIS; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CASE REPORT; COLON CANCER; ENTEROCOCCUS FAECIUM; FUNGEMIA; HEMICOLECTOMY; HUMAN; INTENSIVE CARE; MALE; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCANDINAVIA; SEPSIS; SEPTIC SHOCK;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEROIDES FRAGILIS; BACTEROIDES INFECTIONS; COLONIC NEOPLASMS; DENMARK; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EUROPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS;

EID: 84869462415     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.049825-0     Document Type: Article

References (28)

1. Bartha, N. A., Só ki, J., Urbá n, E. & Nagy, E. (2011). Investigation of the prevalence of tetQ, tetX and tetX1 genes in Bacteroides strains with elevated tigecycline minimum inhibitory concentrations. Int J Antimicrob Agents 38, 522-525.
2. Dubreuil, L. & Odou, M. F. (2010). Anaerobic bacteria and antibiotics: what kind of unexpected resistance could I find in my laboratory tomorrow? Anaerobe 16, 555-559.
3. García, N., Gutié rrez, G., Lorenzo, M., Vadillo, S., Píriz, S. & Quesada, A. (2009). Gene context and DNA rearrangements in the carbapenemase locus of division II strains of Bacteroides fragilis. Antimicrob Agents Chemother 53, 2677-2678.
4. Kato, N., Yamazoe, K., Han, C.-G. & Ohtsubo, E. (2003). New insertion sequence elements in the upstream region of cfiA in imipenem-resistant Bacteroides fragilis strains. Antimicrob Agents Chemother 47, 979-985.
5. Katsandri, A., Papaparaskevas, J., Pantazatou, A., Petrikkos, G. L., Thomopoulos, G., Houhoula, D. P. & Avlamis, A. (2006). Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains. J Clin Microbiol 44, 3465-3467.
6. Lö fmark, S., Fang, H., Hedberg, M. & Edlund, C. (2005). Inducible metronidazole resistance and nim genes in clinical Bacteroides fragilis group isolates. Antimicrob Agents Chemother 49, 1253-1256.
7. Lö fmark, S., Edlund, C. & Nord, C. E. (2010). Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis 50 (Suppl. 1), S16-S23.
8. Nagy, E. (2010). Anaerobic infections: update on treatment considerations. Drugs 70, 841-858.
9. Nagy, E., Só ki, J., Urban, E., Szö ke, I., Fodor, E. & Edwards, R. (2001). Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary. Acta Biol Hung 52, 271-280.
10. Nagy, E., Urbá n, E., Nord, C. E. & ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria (2011). Antimicrobial susceptibility of Bacteroides fragilis group isolates i n Europe: 20 years of experience. Clin Microbiol Infect 17, 371-379.
11. Nguyen, M. H., Yu, V. L., Morris, A. J., McDermott, L., Wagener, M. W., Harrell, L. & Snydman, D. R. (2000). Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis 30, 870-876.
12. Podglajen, I., Breuil, J., Bordon, F., Gutmann, L. & Collatz, E. (1992). A silent carbapenemase gene in strains of Bacteroides fragilis can be expressed after a one-step mutation. FEMS Microbiol Lett 70, 21-29.
13. Podglajen, I., Breuil, J. & Collatz, E. (1994). Insertion of a novel DNA sequence, 1S1186, upstream of the silent carbapenemase gene cfiA, promotes expression of carbapenem resistance in clinical isolates of Bacteroides fragilis. Mol Microbiol 12, 105-114.
14. Pumbwe, L., Wareham, D. W., Aduse-Opoku, J., Brazier, J. S. & Wexler, H. M. (2007). Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis. Clin Microbiol Infect 13, 183-189.
15. Roh, K. H., Kim, S., Kim, C.-K., Yum, J. H., Kim, M. S., Yong, D., Jeong, S. H., Lee, K., Kim, J. M. & Chong, Y. (2010). New cfiA variant and novel insertion sequence elements in carbapenem-resistant Bacteroides fragilis isolates from Korea. Diagn Microbiol Infect Dis 66, 343-348.
16. Rotimi, V.O., Khoursheed, M., Brazier, J. S., Jamal, W. Y. & Khodakhast, F. B. (1999). Bacteroides species highly resistant to metronidazole: an emerging clinical problem? Clin Microbiol Infect 5, 166-169.
17. Seifert, H., Dalhoff, A. & PRISMA Study Group (2010). German multicentre survey of the antibiotic susceptibility of Bacteroides fragilis group and Prevotella species isolated from intra-abdominal infections: results from the PRISMA study. J Antimicrob Chemother 65, 2405-2410.
18. Snydman, D. R., Jacobus, N. V., McDermott, L. A., Golan, Y., Goldstein, E. J. C., Harrell, L., Jenkins, S., Newton, D., Pierson, C. & other authors (2011). Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009. Anaerobe 17, 147-151.
19. Só ki, J., Fodor, E., Hecht, D. W., Edwards, R., Rotimi, V. O., Kerekes, I., Urbá n, E. & Nagy, E. (2004). Molecular characterization of imipenemresistant, cfiA-positive Bacteroides fragilis isolates from the USA, Hungary and Kuwait. J Med Microbiol 53, 413-419.
20. Só ki, J., Gal, M., Brazier, J. S., Rotimi, V. O., Urbá n, E., Nagy, E. & Duerden, B. I. (2006). Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains. J Antimicrob Chemother 57, 212-220.
21. Steffens, L. S., Nicholson, S., Paul, L. V., Nord, C. E., Patrick, S. & Abratt, V. R. (2010). Bacteroides fragilis RecA protein overexpression causes resistance to metronidazole. Res Microbiol 161, 346-354.
22. Stubbs, S. L. J., Brazier, J. S., Talbot, P. R. & Duerden, B. I. (2000). PCR-restriction fragment length polymorphism analysis for identification of Bacteroides spp. and characterization of nitroimidazole resistance genes. J Clin Microbiol 38, 3209-3213.
23. Toprak, N. U., Uzunkaya, O. D., Só ki, J. & Soyletir, G. (2012). Susceptibility profiles and resistance genes for carbapenems (cfiA) and metronidazole (nim) among Bacteroides species in a Turkish University Hospital. Anaerobe 18, 169-171.
24. Trinh, S., Haggoud, A., Reysset, G. & Sebald, M. (1995). Plasmids pIP419 and pIP421 from Bacteroides: 5-nitroimidazole resistance genes and their upstream insertion sequence elements. Microbiology 141, 927-935.
25. Turner, P., Edwards, R., Weston, V., Gazis, A., Ispahani, P. & Greenwood, D. (1995). Simultaneous resistance to metronidazole, coamoxiclav, and imipenem in clinical isolate of Bacteroides fragilis. Lancet 345, 1275-1277.
26. Walsh, T. R., Bolmströ m, A., Qwä rnströ m, A. & Gales, A. (2002). Evaluation of a new Etest for detecting metallo-b-lactamases in routine clinical testing. J Clin Microbiol 40, 2755-2759.
27. Wareham, D. W., Wilks, M., Ahmmed, D., Brazier, J. S. & Millar, M. (2005). Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy. Clin Infect Dis 40, e67-e68.
28. Wybo, I., De Bel, A., Soetens, O., Echahidi, F., Vandoorslaer, K., Van Cauwenbergh, M. & Pié rard, D. (2011). Differentiation of cfiAnegative and cfiA-positive Bacteroides fragilis isolates by matrixassisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 49, 1961-1964.